Pages that link to "Q35558576"

The following pages link to OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer (Q35558576):

Displaying 42 items.

• The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets (Q24304999) (← links)
• The Clinical Significance of Phosphorylated Heat Shock Protein 27 (HSPB1) in Pancreatic Cancer (Q26775135) (← links)
• Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer (Q30416144) (← links)
• Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy. (Q33576236) (← links)
• Novel role of VMP1 as modifier of the pancreatic tumor cell response to chemotherapeutic drugs (Q33720758) (← links)
• Lead optimization of dual tubulin and Hsp27 inhibitors (Q33752923) (← links)
• Therapeutic options for the management of pancreatic cancer (Q34093776) (← links)
• Heat shock protein 27 phosphorylation state is associated with cancer progression (Q34292270) (← links)
• Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target (Q36298929) (← links)
• A Targetable Molecular Chaperone Hsp27 Confers Aggressiveness in Hepatocellular Carcinoma (Q36644350) (← links)
• Impact of hyperthermic intraperitoneal chemotherapy on Hsp27 protein expression in serum of patients with peritoneal carcinomatosis. (Q37099476) (← links)
• Heat shock protein 27 is a potential indicator for response to YangZheng XiaoJi and chemotherapy agents in cancer cells. (Q37337809) (← links)
• Synthesis and anticancer mechanism investigation of dual Hsp27 and tubulin inhibitors (Q37373120) (← links)
• Heat shock proteins in hematopoietic malignancies. (Q38015052) (← links)
• Heat shock proteins 27, 40, and 70 as combinational and dual therapeutic cancer targets (Q38085897) (← links)
• The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencing (Q38090427) (← links)
• Contribution of small heat shock proteins to muscle development and function. (Q38179729) (← links)
• Therapeutic oligonucleotides with polyethylene glycol modifications. (Q38296021) (← links)
• The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer (Q38634592) (← links)
• The MAPK-activated protein kinase 2 mediates gemcitabine sensitivity in pancreatic cancer cells (Q38717784) (← links)
• Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential (Q38725577) (← links)
• Heat shock protein antagonists in early stage clinical trials for NSCLC. (Q38748687) (← links)
• Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis (Q38946461) (← links)
• Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF. (Q38969858) (← links)
• Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells (Q39064254) (← links)
• Small heat shock proteins in ageing and age-related diseases (Q39078958) (← links)
• Treatment of breast and lung cancer cells with a N-7 benzyl guanosine monophosphate tryptamine phosphoramidate pronucleotide (4Ei-1) results in chemosensitization to gemcitabine and induced eIF4E proteasomal degradation. (Q39216345) (← links)
• Galeterone and its analogs inhibit Mnk-eIF4E axis, synergize with gemcitabine, impede pancreatic cancer cell migration, invasion and proliferation and inhibit tumor growth in mice (Q41592725) (← links)
• Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach (Q41660505) (← links)
• HSPB1 deficiency sensitizes melanoma cells to hyperthermia induced cell death (Q41989169) (← links)
• A Novel Kinase Function of a Nucleoside-diphosphate-kinase Homolog in P. gingivalis is Critical in Subversion of Host Cell Apoptosis by Targeting Heat-Shock Protein 27. (Q47642202) (← links)
• HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis. (Q52590991) (← links)
• Clinical, prognostic, and therapeutic significance of heat shock protein 27 in bladder cancer. (Q53081415) (← links)
• [Novel partners in the angiogenic switch or how to wake up dormant tumor cells]. (Q53126331) (← links)
• Androgen receptor and heat shock protein 27 co-regulate the malignant potential of molecular apocrine breast cancer. (Q53400964) (← links)
• HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor. (Q54245240) (← links)
• Hsp27 regulates epithelial mesenchymal transition, metastasis and proliferation in colorectal carcinoma (Q58792082) (← links)
• Possible role of Porphyromonas gingivalis in orodigestive cancers (Q60913525) (← links)
• Heat shock protein 27: a potential biomarker of peritoneal metastasis in epithelial ovarian cancer? (Q85995778) (← links)
• The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer (Q91715704) (← links)
• Chaperoning STAT3/5 by Heat Shock Proteins: Interest of Their Targeting in Cancer Therapy (Q92154779) (← links)
• A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial (Q92668234) (← links)